Examples
| Generic Name | Brand Name |
|---|
| rituximab | Rituxan |
Rituximab is available for
intravenous (IV) use.
How It Works
Rituximab belongs to a group of medications known as
monoclonal antibodies. It is designed to recognize
specific proteins that are found on the surface of some lymphoma cells. The
monoclonal antibody recognizes the protein and locks onto it (like a key in a
lock). This may then trigger the body's immune system to attack and destroy the
cancer cells.
Why It Is Used
Rituximab is used in combination with other chemotherapy
medications to treat
non-Hodgkin's lymphoma (NHL) and
chronic lymphocytic leukemia (CLL). Rituximab is used
with ibritumomab as part of targeted radiation therapy.
How Well It Works
Rituximab is an effective treatment for NHL and CLL. It is used in
combination with other chemotherapy medications.1
Side Effects
Side effects of rituximab are common and may include:
- Fever and chills. This is more common within
the first 1 to 2 hours of the first infusion.
- Swelling of the face,
lips, and eyelids (angioedema).
- Flushing.
- Nausea or
vomiting.
- Skin rash.
- Headache.
- Sore
throat.
See Drug Reference for a full list of side effects. (Drug Reference
is not available in all systems.)
What To Think About
Rituximab should be administered only under the supervision of a
medical oncologist or
hematologist.
In some cases, rituximab has been associated with serious side
effects such as breathing difficulty, heart problems, or severe infection. For
this reason, the use of rituximab is closely watched.
Rituximab may make heart damage worse in people who already have
heart disease. Frequent tests are needed to monitor heart function while taking
this medication.
In some people who have a history of
hepatitis B virus (HBV) infection, rituximab may cause
the virus to begin multiplying again, leading to severe liver problems. These
people should have tests to monitor liver function during and for several
months following rituximab treatment. Also, people who have a high risk of HBV
infection should be screened before starting treatment with rituximab to make
sure an HBV infection is not present.
Rituximab may cause birth defects. Do not use this medication if
you are pregnant or wish to become pregnant or father a child while you are
taking it.
Rituximab has only been approved for use by adults. There is no
specific information comparing use of rituximab in children with use in other
age groups.
Complete the
new medication information form (PDF)
(What is a PDF document?)
to help you understand this medication.